Pharma Journalist -

Eurofins Discovery announced its premier offering for integrated drug discovery services. Eurofins Discovery has successfully collaborated with clients in integrated drug discovery…
Read More...

Sun Pharmaceutical Industries Ltd. announced that INFUGEM™ (gemcitabine in sodium chloride injection), for intravenous use, is now commercially available in the U.S. INFUGEM, the first…
Read More...

Ascentage Pharma, a globally-focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, hepatitis B and age-related diseases, announced that it has…
Read More...

Centene Corporation and Washington University School of Medicine in St. Louis announced a partnership to transform and accelerate research into treatments for Alzheimer's disease,…
Read More...

Regeneron Pharmaceuticals and Alnylam Pharmaceuticals announced a collaboration to discover, develop and commercialize new RNA interference (RNAi) therapeutics for a broad range of…
Read More...

SMi reports: In four weeks’ time, Injectable Drug Delivery 2019 will gather an international audience to include regulatory, device design, packaging and formulation professionals. …
Read More...

ViiV Healthcare announced that the US Food and Drug Administration (FDA) approved Dovato, a complete, once-daily, single-tablet regimen of dolutegravir (DTG) 50 mg and lamivudine (3TC)…
Read More...

Celgene Corporation and Acceleron Pharma Inc. announced that Celgene has submitted a Biologics License Application (BLA) for luspatercept, an erythroid maturation agent, for the…
Read More...

UK-based contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, has announced its acquisition of CiVentiChem’s US facility located in Cary, North…
Read More...

Novartis announced that there is a legal dispute with Amgen regarding the collaboration agreements in the field of migraine. On April 2, 2019, Amgen issued a notice of termination of…
Read More...